Oncimmune Holdings plc OCY.SG Stock
Oncimmune Holdings plc Price Chart
Oncimmune Holdings plc OCY.SG Financial and Trading Overview
| Oncimmune Holdings plc stock price | 0.24 EUR |
| Previous Close | 0.19 EUR |
| Open | 0.19 EUR |
| Bid | 0.19 EUR x N/A |
| Ask | 0.23 EUR x N/A |
| Day's Range | 0.19 - 0.19 EUR |
| 52 Week Range | 0.19 - 1.17 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 17.24M EUR |
| Beta (5Y Monthly) | 0.655172 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OCY.SG Valuation Measures
| Enterprise Value | 22.79M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.689841 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.521 |
| Enterprise Value/EBITDA | -3.534 |
Trading Information
Oncimmune Holdings plc Stock Price History
| Beta (5Y Monthly) | 0.655172 |
| 52-Week Change | -80.41% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.17 EUR |
| 52 Week Low | 0.19 EUR |
| 50-Day Moving Average | 0.38 EUR |
| 200-Day Moving Average | 0.55 EUR |
OCY.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 74.14M |
| Float | 49.92M |
| Short Ratio | N/A |
| % Held by Insiders | 32.65% |
| % Held by Institutions | 37.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -256.20% |
| Gross Margin | 48.20% |
| EBITDA Margin | -212.82% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 3.03M EUR |
| Revenue Per Share (ttm) | 0.04 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -6449600 EUR |
| Net Income Avi to Common (ttm) | -9108800 EUR |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 780K EUR |
| Total Cash Per Share (mrq) | 0.01 EUR |
| Total Debt (mrq) | 10.42M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.462 |
| Book Value Per Share (mrq) | -0.087 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5497600 EUR |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Oncimmune Holdings plc
| Country | Germany |
| State | N/A |
| City | Nottingham |
| Address | MediCity |
| ZIP | NG90 6BH |
| Phone | 44 1157 840 500 |
| Website | https://www.oncimmune.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc has a collaboration with Siemens Healthineers AG. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
Q&A For Oncimmune Holdings plc Stock
What is a current OCY.SG stock price?
Oncimmune Holdings plc OCY.SG stock price today per share is 0.24 EUR.
How to purchase Oncimmune Holdings plc stock?
You can buy OCY.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncimmune Holdings plc?
The stock symbol or ticker of Oncimmune Holdings plc is OCY.SG.
Which industry does the Oncimmune Holdings plc company belong to?
The Oncimmune Holdings plc industry is Biotechnology.
How many shares does Oncimmune Holdings plc have in circulation?
The max supply of Oncimmune Holdings plc shares is 82.15M.
What is Oncimmune Holdings plc Price to Earnings Ratio (PE Ratio)?
Oncimmune Holdings plc PE Ratio is now.
What was Oncimmune Holdings plc earnings per share over the trailing 12 months (TTM)?
Oncimmune Holdings plc EPS is -0.1 EUR over the trailing 12 months.
Which sector does the Oncimmune Holdings plc company belong to?
The Oncimmune Holdings plc sector is Healthcare.